PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
47.23%
Revenue growth exceeding 1.5x CRWV's 23.55%. David Dodd would verify if faster growth reflects superior business model.
27.66%
Cost growth 1.25-1.5x CRWV's 19.16%. Martin Whitman would scrutinize competitive cost position.
52.75%
Gross profit growth exceeding 1.5x CRWV's 25.15%. David Dodd would verify competitive advantages.
3.75%
Margin expansion exceeding 1.5x CRWV's 1.30%. David Dodd would verify competitive advantages.
0.68%
R&D change of 0.68% while CRWV maintains spending. Bruce Berkowitz would investigate effectiveness.
59.65%
G&A growth while CRWV reduces overhead. John Neff would investigate operational differences.
29.71%
Marketing expense growth less than half of CRWV's 248.84%. David Dodd would verify if efficiency advantage is sustainable.
No Data
No Data available this quarter, please select a different quarter.
22.96%
Operating expenses growth 1.25-1.5x CRWV's 17.97%. Martin Whitman would scrutinize control.
24.54%
Total costs growth 1.25-1.5x CRWV's 18.28%. Martin Whitman would scrutinize control.
No Data
No Data available this quarter, please select a different quarter.
-4.80%
D&A reduction while CRWV shows 26.15% growth. Joel Greenblatt would examine efficiency.
75.00%
EBITDA growth exceeding 1.5x CRWV's 33.05%. David Dodd would verify competitive advantages.
18.81%
EBITDA margin growth exceeding 1.5x CRWV's 7.69%. David Dodd would verify competitive advantages.
89.94%
Operating income growth 50-75% of CRWV's 169.93%. Martin Whitman would scrutinize operations.
29.01%
Operating margin growth below 50% of CRWV's 156.60%. Michael Burry would check for structural issues.
30.74%
Other expenses growth while CRWV reduces costs. John Neff would investigate differences.
86.42%
Pre-tax income growth exceeding 1.5x CRWV's 9.63%. David Dodd would verify competitive advantages.
26.62%
Similar pre-tax margin growth to CRWV's 26.86%. Walter Schloss would investigate industry trends.
86.48%
Tax expense growth above 1.5x CRWV's 3.78%. Michael Burry would check for concerning trends.
86.40%
Net income growth exceeding 1.5x CRWV's 7.67%. David Dodd would verify competitive advantages.
26.61%
Similar net margin growth to CRWV's 25.27%. Walter Schloss would investigate industry trends.
87.50%
EPS growth exceeding 1.5x CRWV's 23.08%. David Dodd would verify competitive advantages.
85.00%
Diluted EPS growth exceeding 1.5x CRWV's 23.08%. David Dodd would verify competitive advantages.
-0.65%
Share count reduction while CRWV shows 20.32% change. Joel Greenblatt would examine strategy.
-0.36%
Diluted share reduction while CRWV shows 20.32% change. Joel Greenblatt would examine strategy.